Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

16.7%

1 terminated/withdrawn out of 6 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

0 of 1 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A

2(66.7%)

Phase 4

1(33.3%)

3Total

N/A(2)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT05766046Not ApplicableActive Not Recruiting

Lung Cancer Prevention Screening Programme in Italy

Role: collaborator

NCT06439875Not ApplicableCompleted

Effects of L-arginine and Liposomial Vitamin C on Severe Copd Patients Undergoing Pulmonary Rehabilitation.

Role: collaborator

NCT04705337Phase 4Terminated

Levosimendan In Ambulatory Heart Failure Patients

Role: collaborator

NCT06699992Not Yet Recruiting

Clinical Application and Usability of Blood Biomarkers As Screening Tool in Alzheimer Disease: a Validation Study

Role: collaborator

NCT05550961Recruiting

APOLLO 11, Consortium of Italian Centers Involved in Treatment of Patients With Lung Cancer Treated With Innovative Therapies: Real World Data and Translational Reaserch

Role: collaborator

NCT04549831Recruiting

Genetic Bases of COVID-19 Clinical Variability

Role: collaborator

All 6 trials loaded